The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Chiral Toxicology: It's the Same Thing…Only Different
Abstract
Chiral substances possess a unique architecture such that, despite sharing identical molecular formulas, atom-to-atom linkages, and bonding distances, they cannot be superimposed. Thus, in the environment of living systems, where specific structure-activity relationships may be required for effect (e.g., enzymes, receptors, transporters, and DNA), the physiochemical and biochemical properties of racemic mixtures and individual stereoisomers can differ significantly. In drug development, enantiomeric selection to maximize clinical effects or mitigate drug toxicity has yielded both success and failure. Further complicating genetic polymorphisms in drug disposition, stereoselective metabolism of chiral compounds can additionally influence pharmacokinetics, pharmacodynamics, and toxicity. Optically pure pharmaceuticals may undergo racemization in vivo, negating single enantiomer benefits or inducing unexpected effects. Appropriate chiral antidotes must be selected for therapeutic benefit and to minimize adverse events. Enantiomers may possess different carcinogenicity and teratogenicity. Environmental toxicology provides several examples in which compound bioaccumulation, persistence, and toxicity show chiral dependence. In forensic toxicology, chiral analysis has been applied to illicit drug preparations and biological specimens, with the potential to assist in determination of cause of death and aid in the correct interpretation of substance abuse and "doping" screens. Adrenergic agonists and antagonist, nonsteroidal anti-inflammatory agents, SSRIs, opioids, warfarin, valproate, thalidomide, retinoic acid, N-acetylcysteine, carnitine, penicillamine, leucovorin, glucarpidase, pesticides, polychlorinated biphenyls, phenylethylamines, and additional compounds will be discussed to illustrate important concepts in "chiral toxicology."
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
Compendium of chemical terminology
Gold, V. (1987) · Cited by 2,525
Lammer, E. J., Chen, D. T., Hoar, R. M., Agnish, N. D., Benke, P. J., Braun, J. T., Curry, C. J., Fernhoff, P. M., Grix, A. W., Lott, I. T., et al. (1985) · New England Journal of Medicine · doi:10.1056/nejm198510033131401 · Cited by 1,942
Specification of Molecular Chirality
Cahn, R. S., Ingold, C., & Prelog, V. (1966) · Angewandte Chemie International Edition in English · doi:10.1002/anie.196603851 · Cited by 1,877
Waldo, A. L., Camm, A. J., deRuyter, H., Friedman, P. L., MacNeil, D. J., Pauls, J. F., Pitt, B., Pratt, C. M., Schwartz, P. J., & Veltri, E. P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02149-6 · Cited by 1,371
Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose
Smilkstein, M. J., Knapp, G. L., Kulig, K. W., & Rumack, B. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198812153192401 · Cited by 1,102
The specification of asymmetric configuration in organic chemistry
Cahn, R. S., Ingold, C. K., & Prelog, V. (1956) · Experientia · doi:10.1007/bf02157171 · Cited by 800
Human P450 metabolism of warfarin
Kaminsky, L. S., & Zhang, Z.-Y. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(96)00140-4 · Cited by 798
Understanding and Managing Methotrexate Nephrotoxicity
Widemann, B. C., & Adamson, P. C. (2006) · The Oncologist · doi:10.1634/theoncologist.11-6-694 · Cited by 730
Anderson, J. L., Horne, B. D., Stevens, S. M., Grove, A. S., Barton, S., Nicholas, Z. P., Kahn, S. F. S., May, H. T., Samuelson, K. M., Muhlestein, J. B., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.737312 · Cited by 727
Cited by
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
Hiemke, C., Baumann, P., Bergemann, N., Conca, A., Dietmaier, O., Egberts, K., Fric, M., Gerlach, M., Greiner, C., Gründer, G., et al. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1286287 · Cited by 868
Applications of Deuterium in Medicinal Chemistry
Pirali, T., Serafini, M., Cargnin, S., & Genazzani, A. A. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01808 · Cited by 855
Chiral 2D Perovskites with a High Degree of Circularly Polarized Photoluminescence
Ma, J., Fang, C., Chen, C., Jin, L., Wang, J., Wang, S., Tang, J., & Li, D. (2019) · ACS Nano · doi:10.1021/acsnano.9b00302 · Cited by 581
Endocrine Disruptors and Asthma-Associated Chemicals in Consumer Products
Dodson, R. E., Nishioka, M., Standley, L. J., Perovich, L. J., Brody, J. G., & Rudel, R. A. (2012) · Environmental Health Perspectives · doi:10.1289/ehp.1104052 · Cited by 542
Ahn, J., Lee, E., Tan, J., Yang, W., Kim, B., & Moon, J. (2017) · Materials Horizons · doi:10.1039/c7mh00197e · Cited by 485
Radioactive Main Group and Rare Earth Metals for Imaging and Therapy
Kostelnik, T. I., & Orvig, C. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00294 · Cited by 483
Pharmacologically active compounds in the environment and their chirality
Kasprzyk-Hordern, B. (2010) · Chemical Society Reviews · doi:10.1039/c000408c · Cited by 456
Zaera, F. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00905 · Cited by 425
Suzuki, N., Wang, Y., Elvati, P., Qu, Z.-B., Kim, K., Jiang, S., Baumeister, E., Lee, J., Yeom, B., Bahng, J. H., et al. (2016) · ACS Nano · doi:10.1021/acsnano.5b06369 · Cited by 397
Nanophotonic Approaches for Chirality Sensing
Warning, L. A., Miandashti, A. R., McCarthy, L. A., Zhang, Q., Landes, C. F., & Link, S. (2021) · ACS Nano · doi:10.1021/acsnano.1c04992 · Cited by 342
Chiral pharmaceuticals: A review on their environmental occurrence and fate processes
Sanganyado, E., Lu, Z., Fu, Q., Schlenk, D., & Gan, J. (2017) · Water Research · doi:10.1016/j.watres.2017.08.003 · Cited by 292
Lateral chirality-sorting optical forces
Hayat, A., Mueller, J. P. B., & Capasso, F. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1516704112 · Cited by 277
Chirality of New Drug Approvals (2013–2022): Trends and Perspectives
McVicker, R. U., & O’Boyle, N. M. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02239 · Cited by 255
Chirality in adsorption on solid surfaces
Zaera, F. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00367f · Cited by 172
Mass-resolved electronic circular dichroism ion spectroscopy
Daly, S., Rosu, F., & Gabelica, V. (2020) · Science · doi:10.1126/science.abb1822 · Cited by 68
Essential Medicinal Chemistry of Essential Medicines
Serafini, M., Cargnin, S., Massarotti, A., Pirali, T., & Genazzani, A. A. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00415 · Cited by 46
Metadata
- Authors
- Smith, S. W.
- Venue
- Toxicological Sciences
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-05-04
- Volume
- 110
- Issue
- 1
- Pages
- 4-30
- ISSN
- 1096-0929 (ISSN-L)
- 1096-6080
- OpenAlex
- W2163008413
- Cited by
- 602
- References
- 172
- FWCI
- 8.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.